After landmark research that new Alzheimer's drugs make 'no meaningful difference' to patients, we reveal the simple daily tweaks PROVEN to lower your risk of dementia
Momentous - that's how one leading UK dementia charity described the approval of the Alzheimer's drug lecanemab back in August 2024.
Original Source
Read the full article at Dailymail →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.